Download PDF
Nuklearmedizin 1984; 23(06): 277-282
DOI: 10.1055/s-0038-1624257
Originalarbeiten — Original Articles
Schattauer GmbH

Determination of Myocardial FFA Elimination Rates by Functional Images of Uncorrected Half-Time Values

Bestimmung von FFA-EIiminationsraten des Myokards anhand von Funktionsbildem unkorrigierter Halb wertszeiten
F. C. Visser
*   From the Dept, of Cardiology, Amsterdam, The Netherlands
,
A. Van Lingen
**   Dept, of Nuclear Medicine, Free University Hospital, Amsterdam, The Netherlands
,
G. Westera
**   Dept, of Nuclear Medicine, Free University Hospital, Amsterdam, The Netherlands
,
M. J. Eenige van
*   From the Dept, of Cardiology, Amsterdam, The Netherlands
,
W. Den Hollander
**   Dept, of Nuclear Medicine, Free University Hospital, Amsterdam, The Netherlands
,
E. E. Van der Wall
*   From the Dept, of Cardiology, Amsterdam, The Netherlands
,
G. A. K. Heidendal
**   Dept, of Nuclear Medicine, Free University Hospital, Amsterdam, The Netherlands
,
J. P. Roos
*   From the Dept, of Cardiology, Amsterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Received: 09 January 1984

accepted in revised form: 18 May 1984

Publication Date:
11 January 2018 (online)

Also available at
    Permissions and Reprints

Summary

This paper presents an alternative method of demarcating regions of in terest over the myocardium after ad ministration of 123I-heptadecanoic acid to patients with coronary artery disea se. In a matrix of 32 × 32 pixels the elimination rates of the radioactivity, which are not corrected for back ground activity, are visualized per pixel in a functional image. The func tional image showed areas in the myocardium with high values of uncorrected elimination rates. These areas corresponded with the tracer defects on the scintigram. Corrected elimination rates obtained from re gions of interest of functional images were comparable with those of scinti grams. Thus based on functional im ages of uncorrected elimination rates a reliable, objective determination of regions of interest over normal and abnormal myocardium can be made.

Zusammenfassung

Beschrieben wird eine al ternative Methode für die Abgren zung von Regions of Interest (ROI) über dem Myokard nach Applikation von 123J-Heptadekansäure bei Patien ten mit koronarer Herzerkrankung. In einer Matrix von 32 × 32 Pixel werden die Eliminationsraten der Aktivität pro Pixel, nicht korrigiert für die Hintergrundaktivität, als Funktions bild gezeigt. Dieses zeigt Gebiete des Myokards mit hohen Werten für die unkorrigierten Eliminationsraten. Diese Bezirke stimmen mit Speicher defekten im Szintigramm überein. Die korrigierten Eliminationsraten, wel che aus Regions of Interest von Funk tionsbildern erhalten werden, waren mit denen des Szintigramms vergleich bar. Folglich kann eine zuverlässige und objektive Abgrenzung von Regions of Interest über normalem und abnormalem Myokard anhand von Funktionsbildern und korrigierten Eli minationsraten vorgenommen wer den.

 

  • References

  • 1 Comet M, Wolf J. E., Pilichowski P, Mathieu J. P., Dubois F, Riche F, Busquet G, Vidal M, Godart J, Pernin et. M, Gaudy C. Influence du propranolol sur l’activité myocardique après injection i.v. d’acide 16 I (123) hexadecene 9 oique. In Non-Invasive Methods in Ischemic Heart Disease.. 1982. Faivre G, Bertrand A, Cherrier F, Amor M, Neimann J. L.. (Eds.) 295-9.
    Google Scholar
  • 2 Cook D. J., Bailey I, Strauss H. W., Rouleau J, Wagner Jr H. N., Pitt Jr B. Thallium-201 for myocardial imaging. Appearance of the normal heart. J. nucl. Med. 1976; 17: 583-9.
    PubMedGoogle Scholar
  • 3 Dudczak R, Schmoliner R, Derfler D. K., Angelberger P, Kletter K, Losert U, Frischauf H. Effect of ischemia and pharmacological intervention on the myo cardial elimination of 1-123 heptadecanoic acid. J. nucl. Med. 1982; 23: 34.
    PubMedGoogle Scholar
  • 4 Feinendegen L. E. Metabolic substrates in the heart free fatty acid metabolism. In Radionuclides in Heart Disease.. 1980: 42 Eur. Soc. Cardiol Oxford:
    Google Scholar
  • 5 Feinendegen L. E., Vyska K, Freund lieb C, Hoeck A, Machulla H. J., Klo ster G, Stoecklin G. Non-invasive ana lysis of metabolic reactions in body tissues, the case of myocardial fatty acids. Eur. J. nucl. Med. 1981; 06: 191-200.
    CrossrefPubMedGoogle Scholar
  • 6 Freundlieb C, Hoeck A, Vyska K, Feinendegen L. E., Machulla H. J., Stoecklin G. Myocardial imaging and meta bolic studies with [17-1-123] iodoheptadecanoic acid. J. nucl. Med. 1980; 21: 1043-50.
    PubMedGoogle Scholar
  • 7 Goris M. L., Daspit S. G., McLaughlin P, Kriss J. P. Interpolative background subtraction. J. nucl. Med. 1976; 17: 744-7.
    PubMedGoogle Scholar
  • 8 Poe N. D., Robinson Jr G. D., Zielinski F. W., Cabeen Jr JW, Gomes A. S. Myocardial imaging with I-123-hexadecenoic acid. Radiology. 1977; 124: 419-24.
    CrossrefPubMedGoogle Scholar
  • 9 Roesler H, Hess T, Weiss M, Noelpp U, Mueller G, Hoeflin F, Kinser J. Tomoscintigraphic assessment of myocardial metabolic heterogeneity. J. nucl. Med. 1983; 24: 285-96.
    PubMedGoogle Scholar
  • 10 Sobel B. E., Weiss E. S., Welch M. J., Siegel B. A., Ter-Pogossian M. M. De tection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous C-ll-palmitate. Circulation. 1977; 55: 853-7.
    CrossrefPubMedGoogle Scholar
  • 11 Van der Wall E. E., Heidendal G. A.K, Den Hollander W, Westera G, Ross J. P. 1-123 labeled hexadecenoic acid in comparison with thallium-201 for myocar dial imaging in coronary heart disease. A preliminary study. Eur. J. nucl. Med. 1980; 05: 401-5.
    CrossrefPubMedGoogle Scholar
  • 12 Van der Wall E. E., Westera G, Heidendal G. A.K, Den Hollander W. A comparison between terminally radioiodinated hexadecenoic acid (125-I-HA) and heptadecanoic acid (131-I-HDA) in the dog heart. Eur. J. nucl. Med. 1981; 06: 581-4.
    CrossrefPubMedGoogle Scholar
  • 13 Van der Wall E. E., Den Hollander W, Heidendal G. A.K, Westera G, Majid P. A., Roos J. P. Dynamic myocar dial scintigraphy with 1-123 labeled free fatty acids in patients with myocardial infarction. Eur. J. nucl. Med. 1981; 06: 383-90.
    CrossrefPubMedGoogle Scholar
  • 14 Van der Wall E. E., Heidendal G. A.K, Den Hollander W, Westera G, Roos J. P. Metabolic myocardial imaging with 1-123 labeled heptadecanoic acid in pa tients with angina pectoris. Eur. J. nucl. Med. 1981; 06: 391-6.
    CrossrefPubMedGoogle Scholar
  • 15 Westera G, Van der Wall E. E., Heidendal G. A. K, Van den Bos G. C. A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and Tl201-thallium chloride in the dog heart. Implications for the use of I-HA for myo cardial imaging. Eur. J. nucl. Med. 1980; 05: 339-43.
    CrossrefPubMedGoogle Scholar